Taivital
Biopharmaceutical Co. LTD is a promising biotechnology company
with a GMP plant facility committed to the
manufacturing and development of the highest quality of antibodies
for in vitro clinical diagnosis. Our innovative Linear Array
Epitope (LAE) technology distinguishes us from all others in immunogen design.
This new technique combines the use of receptor-mediated uptake and an
efficient antigen presentation to allow the induction of immune responses to
generate antibodies with high affinity and high specificity against any
antigen (including self-antigen). State-of-the-art technology combined with
years of experience in immunogen preparation and antibody purification assures
that we deliver superior immunogens and antibodies at affordable prices. Additionally,
we specialize in a new affinity purification
technology that purifies antibodies and offer this service
to customers who need a GMP plant facility to prepare IVD
antibodies.
|